Replies to post #2104 on Revance Therapeutics Inc (RVNC)

[DewDiligence]

I was referring to the US market specifically, but eventually Daxi should sell well everywhere, including “emerging markets.” In emerging markets, as emerging middle classes gain disposable income one of the things they will spend it on is looking good.

RVNC has a Daxi commercialization partner, Fosun Pharma, for Greater China—including Hong Kong and Taiwan (#msg-145245703). If RVNC has not already been acquired, they will presumably seek partners for Daxi commercialization in the rest of the world.